Significantly inhibitory effects of low molecular weight heparin (Fraxiparine) on the motility of lung cancer cells and its related mechanism
Guo-xing Zhong et al, 2015, Tumor Biology CrossRef
Combination of nadroparin with radiotherapy results in powerful synergistic antitumor effects in lung adenocarcinoma A549 cells
Xibing Zhuang et al, 2016, Oncology Reports CrossRef
Randomised phase II trial of gemcitabine and nab-paclitaxel with necuparanib or placebo in untreated metastatic pancreas ductal adenocarcinoma
Eileen M. O'Reilly et al, 2020, European Journal of Cancer CrossRef
Antiproliferative Activity of Glycosaminoglycan-Like Polysaccharides Derived from Marine Molluscs
Abdullah Faisal Aldairi et al, 2018, Marine Drugs CrossRef
Non-Anticoagulant Activities of Low Molecular Weight Heparins—A Review
Ke Feng et al, 2023, Pharmaceuticals CrossRef
Anti-metastasis efficacy and safety of non-anticoagulant heparin derivative versus low molecular weight heparin in surgical pancreatic cancer models
REEM ALYAHYA et al, 2015, International Journal of Oncology CrossRef
Extracellular matrix functions in lung cancer
Martin Götte et al, 2018, Matrix Biology CrossRef
Synergistic effects of eukaryotic coexpression plasmid carrying LKB1 and FUS1 genes on lung cancer in vitro and in vivo
Lingdong Li et al, 2014, Journal of Cancer Research and Clinical Oncology CrossRef
Rivaroxaban versus nadroparin for preventing deep venous thrombosis after total hip arthroplasty following femoral neck fractures: A retrospective comparative study
Chi Zhang et al, 2018, Journal of International Medical Research CrossRef
Development of low molecular weight heparin by H2O2/ascorbic acid with ultrasonic power and its anti-metastasis property
Xuemin Shen et al, 2019, International Journal of Biological Macromolecules CrossRef
Low molecular weight heparin and cancer survival: clinical trials and experimental mechanisms
Ning Zhang et al, 2016, Journal of Cancer Research and Clinical Oncology CrossRef